ArticleFrontiers in pharmacology2022

Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis.

Xiaohui Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.